The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-26
DOI
10.3389/fimmu.2020.557586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer
- (2020) Shengnan Yu et al. Frontiers in Oncology
- Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
- (2020) Laura Strauss et al. Science Immunology
- Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics
- (2020) Hamad Alshetaiwi et al. Science Immunology
- Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC
- (2020) Chiara Porta et al. CANCER RESEARCH
- Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
- (2020) Wahafu Alafate et al. CNS Neuroscience & Therapeutics
- Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation
- (2020) Maud D'Aveni et al. Frontiers in Immunology
- CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
- (2020) Markus Eckstein et al. Cancers
- CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma
- (2019) Zaosong Zheng et al. Frontiers in Oncology
- Chemokine Receptor Redundancy and Specificity Are Context Dependent
- (2019) Douglas P. Dyer et al. IMMUNITY
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
- (2019) Cristina Travelli et al. CANCER RESEARCH
- TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4
- (2019) Qian Liang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells
- (2019) Xiteng Yin et al. CELLULAR ONCOLOGY
- Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
- (2019) Francesca Maria Consonni et al. Frontiers in Immunology
- CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
- (2019) Yongning Lu et al. Cell Communication and Signaling
- TNF-like ligand 1A is associated with progression and prognosis of human gastric cancer
- (2019) Yaxian Gao et al. OncoTargets and Therapy
- CCL5 protein level: influence on breast cancer staging and lymph nodes commitment
- (2019) Daniela Rudgeri Derossi et al. MOLECULAR BIOLOGY REPORTS
- Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
- (2019) Philipp Metzger et al. Journal for ImmunoTherapy of Cancer
- The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer
- (2019) YURIE YAMAMOTO et al. ANTICANCER RESEARCH
- Significant association between high serum CCL5 levels and better disease‐free survival of patients with early breast cancer
- (2019) Yukie Fujimoto et al. CANCER SCIENCE
- Expressions of IL-17 and TNF-α in patients with Hashimoto’s disease combined with thyroid cancer before and after surgery and their relationship with prognosis
- (2019) N. Zhang et al. Clinical & Translational Oncology
- Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
- (2019) Bao-Hua Li et al. MOLECULAR IMMUNOLOGY
- Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications
- (2019) Jingxuan Shan et al. Frontiers in Oncology
- CD103+Tumor-Resident CD8+T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
- (2018) Jarem Edwards et al. CLINICAL CANCER RESEARCH
- Plasticity and biological diversity of myeloid derived suppressor cells
- (2018) Kerem Ben-Meir et al. CURRENT OPINION IN IMMUNOLOGY
- Plasticity of myeloid-derived suppressor cells in cancer
- (2018) Evgenii Tcyganov et al. CURRENT OPINION IN IMMUNOLOGY
- How post-translational modifications influence the biological activity of chemokines
- (2018) Vincent Vanheule et al. CYTOKINE
- Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer
- (2018) Liu Yang et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin
- (2018) Stéphanie Corgnac et al. Frontiers in Immunology
- T-cell–Secreted TNFα Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer
- (2018) Mohamad F. Al Sayed et al. CANCER RESEARCH
- Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial
- (2018) Mitsukuni Suenaga et al. EUROPEAN JOURNAL OF CANCER
- Glioma exosomes mediate the expansion and function of myeloid‐derived suppressor cells through microRNA‐29a/ Hbp1 and microRNA‐92a/ Prkar1a pathways
- (2018) Xiaofan Guo et al. INTERNATIONAL JOURNAL OF CANCER
- High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer
- (2018) Marja Heiskala et al. VIRCHOWS ARCHIV
- Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow
- (2017) Mikael Roussel et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways
- (2017) Jingkun Zhao et al. Molecular Cancer
- CCL26 Participates in the PRL-3–Induced Promotion of Colorectal Cancer Invasion by Stimulating Tumor-Associated Macrophage Infiltration
- (2017) Qiusheng Lan et al. MOLECULAR CANCER THERAPEUTICS
- High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma
- (2017) Kai Sun et al. Molecular Medicine Reports
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer
- (2017) Jia Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- p16Ink4a and p21Cip1/Waf1 promote tumour growth by enhancing myeloid-derived suppressor cells chemotaxis
- (2017) Atsushi Okuma et al. Nature Communications
- CCR5 Directs the Mobilization of CD11b + Gr1 + Ly6C low Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Development
- (2017) Elias Hawila et al. Cell Reports
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
- (2016) Niels Halama et al. CANCER CELL
- CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
- (2016) Alan L. Chang et al. CANCER RESEARCH
- Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1 + Tumor-Associated Neutrophils through CCL15-CCR1 Axis
- (2016) Takamasa Yamamoto et al. CLINICAL CANCER RESEARCH
- Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid
- (2016) Christian Schläger et al. NATURE
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma
- (2016) Yuanfeng Yang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis
- (2016) Tie Wang et al. International Journal of Surgery
- Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
- (2016) Amy W Ku et al. eLife
- Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma
- (2015) M Sadeghi et al. BRITISH JOURNAL OF CANCER
- ROR1C Regulates Differentiation of Myeloid-Derived Suppressor Cells
- (2015) Dmitry Gabrilovich et al. CANCER CELL
- RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis
- (2015) Laura Strauss et al. CANCER CELL
- Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages
- (2015) C. Frankenberger et al. CANCER RESEARCH
- CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer
- (2015) Q. Zhang et al. CANCER RESEARCH
- Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis
- (2015) S. Inamoto et al. CLINICAL CANCER RESEARCH
- CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
- (2015) YueGuo Li et al. Hepatology International
- CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3
- (2015) Qiu Tang et al. INFLAMMATION
- Erratum to: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
- (2015) Seok Jin Kim et al. Journal of Hematology & Oncology
- Transcriptional regulation of myeloid-derived suppressor cells
- (2015) Thomas Condamine et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer
- (2015) Lujia Chen et al. Journal of Translational Medicine
- The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts
- (2015) Anne-France le Rolle et al. Journal of Translational Medicine
- CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients
- (2015) Xi Zhu et al. TUMOR BIOLOGY
- CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion
- (2015) Yueguo Li et al. TUMOR BIOLOGY
- CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer
- (2015) Yixin Ding et al. Oncotarget
- Phenotype and function of CXCR5+CD45RA−CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis
- (2015) Zhaojun Duan et al. Oncotarget
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas
- (2014) Shuji Mikami et al. INTERNATIONAL JOURNAL OF CANCER
- ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
- (2014) Thomas Condamine et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells
- (2014) L. Li et al. JOURNAL OF IMMUNOLOGY
- CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
- (2014) Igor Tsaur et al. Cancer Research and Treatment
- Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer
- (2013) C. Bodelon et al. ANNALS OF ONCOLOGY
- The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
- (2013) Laura K Mackay et al. NATURE IMMUNOLOGY
- The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: Cousins, siblings or twins?
- (2013) Sven Brandau et al. SEMINARS IN CANCER BIOLOGY
- Serum Levels of the Chemokine CXCL13, Genetic Variation in CXCL13 and Its Receptor CXCR5, and HIV-Associated Non-Hodgkin B-Cell Lymphoma Risk
- (2012) S. K. Hussain et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells
- (2012) Yan Zhang et al. CELL RESEARCH
- Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis
- (2012) Liat Izhak et al. PLoS One
- Effect of IL-1β and TNF-α polymorphisms on the prognosis and survival of gastric cancer patients
- (2011) Tomomitsu Tahara et al. CLINICAL AND EXPERIMENTAL MEDICINE
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
- (2011) Benjamin Toh et al. PLOS BIOLOGY
- IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement
- (2010) Bainan Liu et al. EXPERIMENTAL HEMATOLOGY
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Fusion Protein Encoding the Second Extracellular Domain of CCR5 Arrests Chemokine-Induced Cosignaling and Effectively Suppresses Ongoing Experimental Autoimmune Encephalomyelitis
- (2010) Y. Sapir et al. JOURNAL OF IMMUNOLOGY
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- CCR5 Proinflammatory Allele in Prostate Cancer Risk
- (2009) Carmela Rita Balistreri et al. Annals of the New York Academy of Sciences
- Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
- (2009) Alberto Mantovani et al. HUMAN IMMUNOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
- (2008) J Panse et al. BRITISH JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now